Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Nanomedicine (28)
- Pharmacy and Pharmaceutical Sciences (25)
- Pharmaceutics and Drug Design (20)
- Life Sciences (14)
- Diseases (10)
-
- Chemicals and Drugs (9)
- Pharmacology, Toxicology and Environmental Health (8)
- Virus Diseases (8)
- Pharmaceutical Preparations (7)
- Immunology and Infectious Disease (5)
- Medical Sciences (5)
- Medicinal Chemistry and Pharmaceutics (5)
- Pharmacology (5)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (4)
- Therapeutics (4)
- Biomedical Engineering and Bioengineering (3)
- Engineering (3)
- Medical Specialties (3)
- Medicinal and Pharmaceutical Chemistry (3)
- Other Pharmacy and Pharmaceutical Sciences (3)
- Biochemistry, Biophysics, and Structural Biology (2)
- Biological Phenomena, Cell Phenomena, and Immunity (2)
- Biology (2)
- Biomaterials (2)
- Chemistry (2)
- Disease Modeling (2)
- Immunoprophylaxis and Therapy (2)
- Medical Biotechnology (2)
- Keyword
-
- Nanomedicine (4)
- Pancreatic cancer (4)
- Prodrug (4)
- Macrophage (3)
- Nanoformulation (3)
-
- Nanoparticles (3)
- Cancer (2)
- Drug delivery (2)
- Exosomes (2)
- Formulation (2)
- HBV (2)
- HIV (2)
- HIV-1 (2)
- Nanoparticle (2)
- Nanotechnology (2)
- Prodrugs (2)
- RNA delivery (2)
- Rilpivirine (2)
- 17-AAG (1)
- AIDS (1)
- Aggregation-induced emission (1)
- Akt (1)
- Alzheimer's (1)
- Alzheimer's Disease (1)
- Alzheimer's disease (1)
- Antiretroviral (1)
- Antiretroviral Therapy (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Autoantibodies (1)
Articles 31 - 36 of 36
Full-Text Articles in Nanotechnology
Long-Acting Antiretroviral Nanoformulation Development And Subcellular Trafficking, Dongwei Guo
Long-Acting Antiretroviral Nanoformulation Development And Subcellular Trafficking, Dongwei Guo
Theses & Dissertations
The introduction of nanoformulated antiretroviral therapeutic regimens is a promising alternative to standard once a day oral treatment of HIV infection. Our lab has pioneered this effort and was successful in harnessing mononuclear phagocytes (monocytes, dendritic cells and macrophages) as nanoformulated drug carriers. The approach was developed as Trojan horses for drug transport, delivery and distribution to sites of viral replication in order to facilitate microbial elimination in HIV sanctuaries. However, the remaining challenges for current antiretroviral nanoformulations include to formulate a broad range of hydrophilic short-acting drugs, and to elucidate the mechanism of sequestered nanoparticles in macrophages at the …
Block Copolymer Based Magnetic Nanoclusters For Cancer-Theranostics: Synthesis, Characterization And In Vitro Evaluation, Hemant M. Vishwasrao
Block Copolymer Based Magnetic Nanoclusters For Cancer-Theranostics: Synthesis, Characterization And In Vitro Evaluation, Hemant M. Vishwasrao
Theses & Dissertations
“There is plenty of room at the bottom”. In this visionary lecture in 1959 Prof. Richard Feynman spoke of the interesting ramifications of working with matter at the atomic scale. Since then, scientists have worked relentlessly towards realizing his vision. The influence of nanobiotechnology on material science and polymer chemistry has given rise to a new field called ‘theranostics’, combining drug delivery and diagnostics within the same nanostructures, thereby enabling simultaneous diagnosis, targeted drug delivery and continued therapy monitoring. Iron oxide nanoparticles (MNPs) are one such class of MRI contrast agents that can be converted into theranostic nanomedicines for cancer …
Biodegradable Hybrid Nanogels For Combination Chemotherapy, Swapnil Desale
Biodegradable Hybrid Nanogels For Combination Chemotherapy, Swapnil Desale
Theses & Dissertations
Combination chemotherapy is commonly used to treat cancer, because such a therapy regimens usually involve sequential administration of multiple drugs and allow targeting different cell signaling pathway. The co-delivery of drug combination at a controlled ratio via the same vehicle is offering the advantages such as spatial-temporal synchronization of drug exposure, synergistic therapeutic effects and suppression of drug resistance. Undoubtedly, there are several molecular and pharmacological factors that determine the effectiveness of drug combinations. A rationally designed drug combination is required since certain drug ratios and the definitive exposure to the targets of interest can only be synergistic while others …
Antiviral Peptide Nanocomplexes As Potential Therapeutics For The Treatment Of Infectious Diseases, Jinjin Zhang
Antiviral Peptide Nanocomplexes As Potential Therapeutics For The Treatment Of Infectious Diseases, Jinjin Zhang
Theses & Dissertations
Hepatitis C Virus (HCV) is recognized as a major burden in global public health, which can be further exacerbated by several cofactors such as human immunodeficiency virus (HIV). Currently, there is no vaccine for HCV. The emergence of potent and highly specific direct-acting antivirals (DAA) has marked a new era in HCV therapy, however, the remaining issues like affordability, genotype dependency, and potential resistance still necessitate the development of additional therapeutic approaches to be used instead or in combination with DAA.
Recently, the antiviral peptide C5A (in our studies designated as p1) and its cationic derivative p41 have been identified …
Targeted Magnetite Tissue Delivery For Antiretroviral Pharmacokinetics, Tianyuzi Li
Targeted Magnetite Tissue Delivery For Antiretroviral Pharmacokinetics, Tianyuzi Li
Theses & Dissertations
Pharmacokinetics and pharmacodynamics studies are required for bench to bedside translation of any new drug, formulation or device. Multifunctional magnetite nanocarriers enable magnetic resonance imaging tracking of nanomaterial encased antiretroviral drugs serving to improve the effectiveness of formulation developments. Targeting ligands used to deliver nanoparticles to HIV harboring cells can be tested using multifunctional magnetite nanocarriers. To this end, two types of magnetite nanocarriers were developed. These included small magnetite antiretroviral therapy particles. The second were ALN-PEG coated magnetite particles for testing macrophages targeting ligands. Overall, these works should serve to speed the development of long acting nanoformulated ART to …
Polymeric Nanocarriers For Treatment Of Melanoma And Genetically Modified Mesenchymal Stem Cells To Improve Outcome Of Islet Transplantation, Vaibhav Mundra
Polymeric Nanocarriers For Treatment Of Melanoma And Genetically Modified Mesenchymal Stem Cells To Improve Outcome Of Islet Transplantation, Vaibhav Mundra
Theses & Dissertations
Melanoma is a lethal malignancy with limited treatment options for advanced metastatic stages. New targeted therapeutic options with discovery of BRAF and MEK inhibitors have shown significant survival benefit. Despite the recent progress, inefficient tumor accumulation and dose limiting systemic toxicity remains pressing challenges for treating metastatic melanoma and there is a need for drug delivery approach to improve therapeutic index of chemotherapeutics. Nanoparticle based drug delivery represents promising approach to enhance efficacy and reduce the dose limiting systemic toxicity. Nanoparticles can be formulated either by physical encapsulation of drugs or by covalent conjugation of drugs to the polymeric backbone. …